|
|
||||||||
From the Departments of Neurological Sciences (Drs. Kompoliti, Comella, Goetz, and J.A. Jaglin) and Preventive Medicine (Dr. Leurgans and R. Raman), RushPresbyterianSt Lukes Medical Center, Rush University, Chicago, IL.
Address correspondence and reprint requests to Dr. Katie Kompoliti, Department of Neurological Science, Section of Movement Disorders, 1725 W. Harrison Street, Suite 755, Chicago, IL 60612; e-mail: kkompoli{at}rush.edu
Questionnaire studies have found that parkinsonism worsens in women during the premenstrual period, when estrogen and progesterone levels are presumably at their nadir. To assess this patient-based observation and correlate motor signs with hormonal levels, the authors prospectively studied 10 menstruating women with PD in their "off" state, on 5 successive weeks. Although PD severity fluctuated during the study period, there was no significant correlation between the objective or subjective measures of parkinsonism and estrogen and progesterone levels.1574
This article has been cited by other articles:
![]() |
L. J. Currie, M. B. Harrison, J. M. Trugman, J. P. Bennett, and G. F. Wooten Postmenopausal Estrogen Use Affects Risk for Parkinson Disease Arch Neurol, June 1, 2004; 61(6): 886 - 888. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |